Paeds Vivas · fetal-neonatal-and-perinatal
Apnoea of prematurity — structured oral (viva)
Branching structured oral on a preterm infant with recurrent apnoea, testing definition, pathophysiology, caffeine pharmacology, and exclusion of secondary causes.
On this page & tools
Target exams
Branch 1 — Definition and classification
Examiner: "What is apnoea of prematurity, and how do you define an event?" Candidate: Apnoea of prematurity is a developmental disorder of respiratory control in infants born before 37 weeks, presenting after the first 24 hours. An event is defined as a cessation of breathing for 20 seconds or longer, or a shorter pause with bradycardia below 80 beats per minute, central cyanosis, or desaturation below 80 to 85 percent. [2]
Examiner: "Name the three types. Which is most common?" Candidate: Central apnoea is absent effort and airflow from loss of neural drive; obstructive apnoea preserves effort but loses airflow through upper-airway collapse; and mixed apnoea is a central pause followed by obstruction. Mixed is the most common type, which is why continuous positive airway pressure is often required alongside caffeine. [2]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References2Show ledgerHide ledger
- [1]Schmidt B, Roberts RS, Davis P, et al Caffeine therapy for apnea of prematurity. N Engl J Med, 2006.PMID 16707748
- [2]Erickson G, Dobson NR, Hunt CE Immature control of breathing and apnea of prematurity: the known and unknown. J Perinatol, 2021.PMID 33712716